Chien Sun, PhD
With a strong background in biomedical engineering, Chien has been advising life science clients on product launch, market access strategy, growth strategy, and life cycle management for many years. He has particular expertise in cancer therapeutics, diagnostics, and nanotechnology.
Prior to joining EVERSANA, Chien consulted in the life sciences division at L.E.K. Consulting and led engagements that spanned landscape assessment, value-maximizing strategy, growth strategy, and asset evaluation for leading pharmaceutical and diagnostics companies. He previously was the chief operating officer for The Center for Cell Control, a regional nanomedicine development center funded by the National Institutes of Health, where he led a multi-institutional team of researchers from the University of California at Los Angeles, University of California at Berkeley, and Stanford University. He also founded and served as chief research and development officer for Synlixir Therapeutics, a biotech startup focused on developing combination therapies for early-stage cancers.
Chien received his MS (instrumentation and sensors) and PhD (cancer therapeutics) in biomedical engineering from the University of California at Los Angeles where he was the recipient of the Outstanding MS Award and the Outstanding PhD Award at graduation. As a postdoctoral scholar at UCLA, he developed a novel patented multi-drug platform for the treatment of cancer, eradication of infection, and the differentiation of stem cells. Chien additionally holds a bachelor’s degree in biological sciences from the University of California at Irvine where he graduated Phi Beta Kappa along with other high honors.